Age-related diseases (ARDs)

Antique clock
#Age-related diseases (ARDs) #Ageing #Epigenetics #Healthspan #Multiomics #Rejuvenation therapies

Turning back the epigenetic clock: Can we reverse ageing?

In this article, based on a session at Life Sciences Baltics 2025, Diana Turner reviews the latest research into epigenetics and rejuvenation.  An epigenetic clock is a biomarker of ageing that can be used to estimate ‘biological age’. The method relies on the modifications to DNA that change over time… Read More

#Exclusive Content

Eye
#Age-related diseases (ARDs) #AMD #Fast Track designation #FDA #Ophthalmology #Sanofi

FDA fast-tracks Sanofi’s AMD gene therapy

Sanofi’s investigational one-time intravitreal gene therapy for the treatment of neovascular age-related macular degeneration (AMD) has been granted fast track designation by the US Food and Drug Administration (FDA).   Sanofi’s SAR402663 is currently being evaluated in a Phase I/II clinical trial for patients with neovascular AMD. The gene therapy… Read More

#News #Regulatory

Human neuron
#Age-related diseases (ARDs) #Artificial intelligence (AI) #Biochemistry #Biotechnology #Integrated Biosciences #Neuroscience #Optogenetics

New optogenetic screening platform for drug discovery

Integrated Biosciences, a biotechnology company integrating optogenetics, chemistry and AI to discover small molecule therapeutics for age-related diseases, has published a study in Cell, introducing its optogenetic screening platform. According to the paper, the platform allows for precise and dynamic control of biological targets and processes, unlocking a powerful new… Read More

#News

Grandfather and grandson
#Age-related diseases (ARDs) #Ageing #Rejuvenation therapies #Shift Bioscience #Transcriptomics

Novel single-gene target reverses cellular ageing

Biotechnology company Shift Bioscience has published new research identifying a novel, single-gene target for cellular rejuvenation.   Capable of reversing cellular ageing across multiple cell types, without inducing dangerous pluripotency pathways seen in other approaches, the company says SB000 is well positioned as a target for safer, next-generation… Read More

#Editor's Choice #News

Ageing concept
#Age-related diseases (ARDs) #Ageing #Start-ups

The start-up addressing ageing and disease

DDW Editor Reece Armstrong speaks to Dr Carina Kern, Chief Executive Officer and Chief Scientific Officer, and Serena Kern-Libera, Chief Operating Officer, at LinkGevity about the company’s approach to tackling age-related diseases. RA: Could you tell us about LinkGevity’s approach to developing broad-spectrum therapeutics in the field of ageing?  SK… Read More

#Exclusive Content #Start-up Zone

#Age-related diseases (ARDs) #Genetics / genomics #Medical Research Council #National Institute for Health Research #University of Exeter

Genetic study shines light on causes of multimorbidity

The largest genetic study to date into long-term health conditions of later life has identified opportunities for new ways to treat multiple overlapping conditions.    Currently, nine million people in the UK live with two or more long-term conditions at the same time (multimorbidity). Their treatment accounts for… Read More

#Editor's Choice #News

#Age-related diseases (ARDs) #Ageing #Drug repurposing

How drug repurposing helps treat age-related diseases

Ann Belien, CEO at Rejuvenate Biomed, explores the need for more treatment options for age-related diseases and the opportunities drug repurposing offers these conditions. As the average global lifespan continues to rise, the prevalence of age-related diseases has become an increasing concern. Consequently, treatment options for those diseases are more… Read More

#Business & Investment #Exclusive Content

Ageing hands
#Age-related diseases (ARDs) #Ageing #Peptides #University of Birmingham

Natural peptide could protect against ‘inflammageing’

A naturally occurring peptide called ‘peptide inhibitor of trans-endothelial migration’ (PEPITEM) could potentially rejuvenate the immune response in older individuals, according to a new study. The authors believe the peptide could protect against ‘inflammageing’, widely believed to be the root cause of many age-related diseases. Read More

#News #Trending News

International Space Station (ISS)
#Age-related diseases (ARDs) #Immunotherapy #Muscle atrophy #University of Central Florida #Vaxxinity

Immunotherapy partnership advances space medicine research

US company Vaxxinity and the University of Central Florida (UCF) have announced plans to work together to advance space medicine research. The research, funded by a grant from the State of Florida, aims to develop Vaxxinity’s active immunotherapies to prevent and mitigate muscle and bone wasting. Read More

#News

Human brain
#Age-related diseases (ARDs) #Dementia #Gene mutation #Neurodegenerative disorders #Organoids

Organoid research sheds light on gene mutation linked to dementia

New understanding of a gene that is linked to some forms of dementia and other age-related diseases gives scientists fresh hope that action can be taken against these diseases long before the onset of symptoms. The gene – called Angiogenin or ANG – is associated with… Read More

#Editor's Choice #News

Berlin cityscape
#Age-related diseases (ARDs) #Conference #Events #Rejuvenation therapies #Start-ups

Speakers announced for Rejuvenation Startup Summit 2024

The first set of speakers for Rejuvenation Startup Summit 2024 (Berlin, 10-11 May 2024) has been announced. The networking event aims to bring together startups and members of the longevity venture capital/investor ecosystem to create therapies to vastly extend the healthy human lifespan. In… Read More

#News

Senior couple jogging
#Age-related diseases (ARDs) #clock.bio #Healthspan #iPSC #Regenerative Medicine

clock.bio begins mission to extend health span by 20 years

Longevity biotech clock.bio has launched with $4 million in funding to develop regenerative medicines to prevent and treat age-related diseases. The company says its immediate objective is to decode all rejuvenation programmes present in human cells, to build an atlas of disease and rejuvenation targets for clinical translation. “We have… Read More

#Business & Investment #News

Ageing hands
#Age-related diseases (ARDs) #Ageing #AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #University of Edinburgh

AI algorithms find drugs that could combat ageing

Three drugs that could help stave off the effects of ageing have been discovered using artificial intelligence (AI), a study by Edinburgh researchers suggests. Findings suggest the drugs can safely remove defective cells – known as senescent cells – linked to conditions including cancer, Alzheimer’s disease… Read More

#News

#Age-related diseases (ARDs) #Ageing #AI #Biotechnology #Business #Clinical trials #mRNA

Podcast: The impact of technology on drug discovery

This is the latest episode of the free DDW narrated podcast, “The impact of technology on drug discovery”. It covers two articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Talking Tech” and “Rejuvenation biotech: Can… Read More

#News

Osteoarthritis
#Age-related diseases (ARDs) #Ageing #AKL Therapeutics #Arthritis

Osteoarthritis drug could delay the ageing process

New data suggest that AKL Therapeutics’ investigational oral osteoarthritis (OA) drug APPA may have a dual effect on age-related cellular senescence. Senescence, a process in which cells stop dividing, plays a major role in the development of many age-related diseases, including OA. The study,… Read More

#News #Trending News

Senior couple jogging
#Age-related diseases (ARDs) #Five Alarm Bio #Investment #Seed funding #Start-ups

Anti-ageing therapeutics company completes seed funding

Five Alarm Bio (FAB) has completed a seed investment round, raising over £500K ($605K). The funding will drive proprietary research into novel compounds that extend healthy lifespan of cells and tissues, with therapeutic potential across a broad range of age-related diseases. Investors include Cambridge Angels, Meltwind, o2h Ventures, and SyndicateRoom,… Read More

#News #Start-up Zone